Eastgate Biotech (ETBI) Financial Statements

12 Followers

Eastgate Biotech Financial Overview

Eastgate Biotech's market cap is currently $6.10M. The company's EPS TTM is $-0.0088; its P/E ratio is -1.42; Eastgate Biotech is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 19	Dec 18	Dec 17
Income Statement
Total Revenue	$ 99.73K	$ 136.13K	$ 157.38K
Gross Profit	$ -110.08K	$ -68.88K	$ -3.04K
Operating Income	$ -3.27M	$ -1.35M	$ -3.43M
EBITDA	$ -3.10M	$ -1.23M	$ -3.33M
Net Income	$ -3.54M	$ -1.50M	$ -3.72M
Balance Sheet
Cash & Short-Term Investments	$ 10.19K	$ 4.40K	$ 15.81K
Total Assets	$ 1.28M	$ 1.38M	$ 1.63M
Total Debt	$ 4.50M	$ 3.95M	$ 3.13M
Net Debt	$ 4.49M	$ 3.95M	$ 3.11M
Total Liabilities	$ 10.96M	$ 9.11M	$ 7.35M
Stockholders' Equity	$ -9.68M	$ -7.73M	$ -5.72M
Cash Flow
Free Cash Flow	$ 60.18K	$ -258.16K	$ -1.44M
Operating Cash Flow	$ 113.76K	$ -258.16K	$ -1.40M
Investing Cash Flow	$ -53.57K	$ 0.00	$ -47.61K
Financing Cash Flow	$ 551.90K	$ 701.48K	$ 1.59M

Currency in USD

Eastgate Biotech Earnings and Revenue History

Income Statement >

Eastgate Biotech Debt to Assets

Balance Sheet >

Eastgate Biotech Cash Flow

Cash Flow >

Eastgate Biotech Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >